Vaxart, Inc.
VXRT
$0.347
-$0.01-2.80%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.73M | 20.88M | 15.19M | 4.93M | 6.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.73M | 20.88M | 15.19M | 4.93M | 6.40M |
| Cost of Revenue | 49.74M | 30.74M | 22.65M | 15.07M | 17.48M |
| Gross Profit | -10.01M | -9.87M | -7.47M | -10.13M | -11.08M |
| SG&A Expenses | 4.60M | 5.07M | 4.02M | 4.34M | 5.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.33M | 35.81M | 26.68M | 19.41M | 22.66M |
| Operating Income | -14.60M | -14.94M | -11.49M | -14.48M | -16.26M |
| Income Before Tax | -14.97M | -15.50M | -11.81M | -14.06M | -16.45M |
| Income Tax Expenses | 20.00K | 95.00K | 176.00K | 18.00K | 21.00K |
| Earnings from Continuing Operations | -14.99M | -15.59M | -11.99M | -14.08M | -16.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.99M | -15.59M | -11.99M | -14.08M | -16.47M |
| EBIT | -14.60M | -14.94M | -11.49M | -14.48M | -16.26M |
| EBITDA | -12.41M | -12.69M | -9.26M | -12.25M | -14.04M |
| EPS Basic | -0.07 | -0.07 | -0.05 | -0.06 | -0.09 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.03 | -0.04 | -0.06 |
| EPS Diluted | -0.07 | -0.07 | -0.05 | -0.06 | -0.09 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.03 | -0.04 | -0.06 |
| Average Basic Shares Outstanding | 228.37M | 227.92M | 227.58M | 227.45M | 184.70M |
| Average Diluted Shares Outstanding | 228.37M | 227.92M | 227.58M | 227.45M | 184.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |